Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use

Hideharu Hagiya; Fumio Otsuka

doi:10.1016/j.clinthera.2021.07.007

Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1622-1623
Number of pages	2
Journal	Clinical Therapeutics
Volume	43
Issue number	9
DOIs	https://doi.org/10.1016/j.clinthera.2021.07.007
Publication status	Published - Sept 2021

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1016/j.clinthera.2021.07.007

Cite this

@article{e14503d5aec2443e8e49a85a79de7bd7,

title = "Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use",

author = "Hideharu Hagiya and Fumio Otsuka",

note = "Funding Information: None.",

year = "2021",

month = sep,

doi = "10.1016/j.clinthera.2021.07.007",

language = "English",

volume = "43",

pages = "1622--1623",

journal = "Clinical Therapeutics",

issn = "0149-2918",

publisher = "Excerpta Medica",

number = "9",

}

TY - JOUR

T1 - Ivermectin for Coronavirus Disease 2019

T2 - Yet to Be Well Evaluated Before Clinical Use

AU - Hagiya, Hideharu

AU - Otsuka, Fumio

N1 - Funding Information: None.

PY - 2021/9

Y1 - 2021/9

UR - http://www.scopus.com/inward/record.url?scp=85112527645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85112527645&partnerID=8YFLogxK

U2 - 10.1016/j.clinthera.2021.07.007

DO - 10.1016/j.clinthera.2021.07.007

M3 - Letter

C2 - 34362568

AN - SCOPUS:85112527645

SN - 0149-2918

VL - 43

SP - 1622

EP - 1623

JO - Clinical Therapeutics

JF - Clinical Therapeutics

IS - 9

ER -

Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this